HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients. - Wikidata - awgldk - TriplyDB

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

http://www.wikidata.org/entity/Q35033499

about

Chronic hepatitis C infection and liver disease in HIV-coinfected patients in Asia.HCV co-infection and markers of liver injury and fibrosis among HIV-positive childbearing women in Ukraine: results from a cohort study.Long-term Outcomes After Liver Transplantation Among Human Immunodeficiency Virus-Infected Recipients.Liver Fibrosis Regression Measured by Transient Elastography in Human Immunodeficiency Virus (HIV)-Hepatitis B Virus (HBV)-Coinfected Individuals on Long-Term HBV-Active Combination Antiretroviral Therapy.Correcting for Measurement Error in Time-Varying Covariates in Marginal Structural Models.Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.

P2860

Q36213126-823C3E51-EEA5-47B3-9B71-662CA6713B95 Q36220953-1A1ABF65-3313-4BF6-B90F-8970DDC4AEAA Q36385149-5AC6B7A3-EF50-47A0-9259-9089FD181C3D Q36708245-118459CE-F448-4FCF-80F4-79EFBA55DAEB Q39601889-3A545693-E7C4-4F4D-9280-6FB7D2E5CE4E Q40501796-EF4825F7-6367-43E1-85AA-4B1FEAB8FFCD Q50146220-1024D3B6-59E0-4380-B839-0CA28810F1E4

P2860

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

http://www.wikidata.org/entity/Q35033499

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

HIV virological rebounds but n ...... s C virus-coinfected patients.

@ast

HIV virological rebounds but n ...... s C virus-coinfected patients.

@en

type

label

HIV virological rebounds but n ...... s C virus-coinfected patients.

@ast

HIV virological rebounds but n ...... s C virus-coinfected patients.

@en

prefLabel

HIV virological rebounds but n ...... s C virus-coinfected patients.

@ast

HIV virological rebounds but n ...... s C virus-coinfected patients.

@en

P1433

Q35033499-64E950CD-3585-4353-9D50-F132FB2577A2

P1476

Q35033499-16781BB2-D965-4916-9C9B-37F10BBEA134

P2093

Q35033499-0F6EE6AB-9835-49C6-8481-1F8BD854BC9D

Q35033499-2140F40A-D7A8-492C-BB46-2F362B744D40

Q35033499-2D278B2F-6575-4DA3-9246-42019A6FA286

Q35033499-5B672ED4-8259-4ED7-BEE2-A9551B481788

Q35033499-838462AF-EA4D-4D23-A456-080CAE21DA0A

Q35033499-A4F9611B-CFCF-40C0-B2AA-AAB7D92337CC

Q35033499-FE5AB120-1A19-4188-BE38-4BE03C26EEB6

P2860

Q35033499-0DA20745-1ECF-4045-9478-122FDB0099C5

Q35033499-0F9C8A9E-7D32-48B9-93BB-794629116CDF

Q35033499-216C3503-D673-496C-A945-E9107C1020E8

Q35033499-2F069A78-AAE8-4B1E-843B-2F951836F1DA

Q35033499-31FD844C-77FE-46B4-BDA9-2E3D81A64184

Q35033499-40C558F3-9F0C-4272-ADAD-B67CBB65D5AE

Q35033499-51D80B2A-8334-477E-A78F-4C977D278EFC

Q35033499-5342CA18-8B58-4568-82B3-6CFD3B02CFC1

Q35033499-53C65171-F54C-459B-91D3-946F201FA5AB

Q35033499-5408E95F-C653-488C-BACC-73B3910DA9C2

P304

Q35033499-ADC9CAAE-F96B-4D6C-A8F3-E11BE26874A0

P31

Q35033499-3AB65884-5993-40FF-A21B-03B541CBF80D

P356

Q35033499-768A7B49-53F3-4E0E-8982-8D4D0AB3D906

P433

Q35033499-3EBA93C6-F4C8-49B3-A338-E1C897D3FE0D

P478

Q35033499-06558E7C-7876-49A4-ADBE-B057E7CB3068

P50

Q35033499-1BD42A39-7ED1-42D8-A4FC-189A67ADC324

Q35033499-51B56CDF-15F8-4915-9FB8-BE14C817509C

Q35033499-8681EF23-5983-4F55-90D7-0FF853C8DC37

P577

Q35033499-340B7E41-F09E-48EA-8F68-25AABD32CF5F

P5875

Q35033499-AB445AE9-A44C-4C17-912D-05DE5BF2DBDF

P698

Q35033499-632C9228-2C8C-4F17-A3ED-B7AED52B7B3B

P921

Q35033499-7B6E12A9-CF19-4C3E-955A-85F68A7E1862

Q35033499-8D5D40CA-4C38-44DE-AF80-C651BF874E73

P932

Q35033499-DA753E1D-9B27-4783-B4B6-88BEB1DB0564

P356

P1433

P1476

HIV virological rebounds but n ...... is C virus-coinfected patients

@en

P2093

C Cooper

http://www.w3.org/2001/XMLSchema#string

C Vasquez

http://www.w3.org/2001/XMLSchema#string

Canadian Co-infection Cohort Study Investigators

http://www.w3.org/2001/XMLSchema#string

J Gill

http://www.w3.org/2001/XMLSchema#string

J Young

http://www.w3.org/2001/XMLSchema#string

K C Rollet-Kurhajec

http://www.w3.org/2001/XMLSchema#string

N Pick

http://www.w3.org/2001/XMLSchema#string

P2860

CD4+ count-guided interruption of antiretroviral treatment

Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.

Analysis of binary outcomes in longitudinal studies using weighted estimating equations and discrete-time survival methods: prevalence and incidence of smoking in an adolescent cohort.

Alteration of drug biotransformation and elimination during infection and inflammation.

Mechanisms of cytochrome P450 regulation by inflammatory mediators.

Virological breakthrough: a risk factor for loss to followup in a large community-based cohort on antiretroviral therapy.

Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study.

Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis.

Therapies for HIV and viral hepatitis coinfection.

Viral blip dynamics during highly active antiretroviral therapy.

P304

24-31

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIV.12168

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Mark W. Tyndall

P577

2014-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

262418421

http://www.w3.org/2001/XMLSchema#string

P698

24837567

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4312483

http://www.w3.org/2001/XMLSchema#string